Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Universities - Open for Business Together

8 June 2012

By Stephen Caddick  Vice-Provost (Enterprise) at UCL
At a time of economic and financial crisis, we should expect our universities to carefully consider what they can do to make the UK a more compelling place to carry out business.

This is not an abstract notion: universities up and down the land are taking on the challenge to open them up to the outside world and to ensure the UK is the number one destination for business and industry. Although great progress has been made there is yet more to do if we are to make best use of our world class university sector.

Read the full article at www.huffingtonpost.co.uk